RELX had a 2% increase in underlying revenue at its scientific, technical and medical unit for the first nine months, and said it expects the unit to post modest full-year growth. "RELX Says Nine-Month Underlying Revenue Grew on Year," at 0608 GMT, incorrectly stated that the revenue rise and the guidance were both for RELX as a whole in the first and last paragraphs. The revenue rise and the guidance both refer to the scientific, technical and medical unit alone. The error was also present in "*RELX Underlying Rev. +2% in the First Nine Months" at 0600 GMT.

 

(END) Dow Jones Newswires

October 26, 2017 04:41 ET (08:41 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.
RELX N.V. (NYSE:RENX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas RELX N.V..
RELX N.V. (NYSE:RENX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas RELX N.V..